Bedaquiline susceptibility testing of Mycobacterium abscessus complex and Mycobacterium avium complex: A meta-analysis study
Open Access
- 30 March 2024
- journal article
- review article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 37, 135-140
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2022
- Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosisJournal of Antimicrobial Chemotherapy, 2021
- In vitrosusceptibility ofMycobacterium abscessuscomplex and feasibility of standardizing treatment regimensJournal of Antimicrobial Chemotherapy, 2020
- Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessusACS Infectious Diseases, 2019
- Safety, efficacy, and pharmacokinetics of bedaquiline in Japanese patients with pulmonary multidrug-resistant tuberculosis: An interim analysis of an open-label, phase 2 studyRespiratory Investigation, 2019
- In vitro activity of tedizolid against the Mycobacterium abscessus complexDiagnostic Microbiology and Infectious Disease, 2018
- Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2017
- The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysisJournal of Infection, 2016
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and AcademiaThe Journal of Infectious Diseases, 2015
- FDA Approval of Bedaquiline — The Benefit–Risk Balance for Drug-Resistant TuberculosisNew England Journal of Medicine, 2014